Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease

INTRODUCTION: The optimal combination of amyloid‐β/tau/neurodegeneration (A/T/N) biomarker profiles for the diagnosis of Alzheimer's disease (AD) dementia is unclear. METHODS: We examined the discriminative accuracy of A/T/N combinations assessed with neuroimaging biomarkers for the differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascoal, Tharick A., Leuzy, Antoine, Therriault, Joseph, Chamoun, Mira, Lussier, Firoza, Tissot, Cecile, Strandberg, Olof, Palmqvist, Sebastian, Stomrud, Erik, Ferreira, Pamela C. L., Ferrari‐Souza, João Pedro, Smith, Ruben, Benedet, Andrea Lessa, Gauthier, Serge, Hansson, Oskar, Rosa‐Neto, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Special Issue: Harmonization
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886860/
https://www.ncbi.nlm.nih.gov/pubmed/36733847
http://dx.doi.org/10.1002/dad2.12390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886860/
https://www.ncbi.nlm.nih.gov/pubmed/36733847
http://dx.doi.org/10.1002/dad2.12390

Ejemplares similares